|
Investor Relations
Somaxon Pharmaceuticals is a specialty pharmaceutical company focused on in-licensing and development of proprietary product candidates for the treatment of diseases and disorders in the fields of psychiatry and neurology.
Latest News
Jun 13, 2008
Somaxon Pharmaceuticals Appoints Erle T. Mast and Thomas G. Wiggans to its Board of Directors (pdf)
Jun 12, 2008
Silenor™ Data Presented at the 22nd Annual Meeting of the Associated Professional Sleep Societies
(pdf)
Webcasts
|
| Stock Quote |
SOMX(Common Stock)
Last Trade $3.32
Change  0.11
Exchange NASDAQ
Volume 8,400
07/18/08 4:11 PM ET
Minimum 20 Minute Delay.
Refresh Quote.
|
Annual Report 2007
|
